A. W. Ford‐Hutchinson

Author

Also Known As

A Ford-Hutchinson, A W Ford-Hutchinson, A. Ford-Hutchinson, A. W. FORD-HUTCHINSON, A. W. FORD‐HUTCHINSON, A. W. Ford-Hutchinson, A. W. Ford‐Hutchinson, A.W Ford-Hutchinson, A.W. FORD-HUTCHINSON, A.W. FORD‐HUTCHINSON

131

Publications

7.3K

Citations

H-Index

102

Concepts

All Affiliations

Merck Canada Inc. (Canada)King's College Hospital United States Military Academy King's College - North Carolina

About

A. W. Ford‐Hutchinson is an author at Merck Canada Inc. (Canada) specializing in medicine, inflammation, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	60	5.2K
2	Natural Sciences	10	10	925
3	Health Sciences	3	3	158
4	Education	1	1	18
5	Engineering	1	1	127

A. W. Ford‐Hutchinson

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes A. W. Ford‐Hutchinson, M.A. Bray, Mira Doig, Nature InflammationCytokineGranulocyteMedicineHematology	1980	2.1K
MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. Carol A. Rouzer, A. W. Ford‐Hutchinson, Howard E. Morton, Journal of Biological Chemistry Lipid PeroxidationImmunologyMembrane AssociationRedox BiologyOxidative Stress	1990	316
Leukotriene B: a potential mediator of inflammation M. J. H. Smith, A. W. Ford‐Hutchinson, M.A. Bray Journal of Pharmacy and Pharmacology ImmunologyPharmacotherapyOxidative StressTranslational PharmacologyInflammation	1980	300
Leukotriene B4 in inflammation. A. W. Ford‐Hutchinson PubMed InflammationAnti-inflammatoryLeukotriene B4ImmunologyChronic Inflammation	1990	298
Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D<sub>4</sub> receptor antagonist Thomas R. Jones, Robert Zamboni, Michel Belley, Canadian Journal of Physiology and Pharmacology	1989	270
LEUKOTRIENE B<sub>4</sub>: A MEDIATOR OF VASCULAR PERMEABILITY M.A. Bray, F.M. Cunningham, A. W. Ford‐Hutchinson, British Journal of Pharmacology	1981	247
Anti-inflammatory drugs, prostaglandins and leucocyte migration John R. Walker, M. J. H. Smith, A. W. Ford‐Hutchinson Inflammation Research InflammationAnti-inflammatoryAutoimmune DiseaseGranulocyteMedicine	1976	139
Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase. Jillian F. Evans, D J Nathaniel, Robert Zamboni, Journal of Biological Chemistry Potent InhibitorLipid PeroxidationImmunologyLeukotriene A3Oxidative Stress	1985	129
Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits. Donald W. Nicholson, Awais Ali, J P Vaillancourt, Proceedings of the National Academy of Sciences EngineeringMolecular BiologyChemical BiologyEnzymatic ModificationHomodimeric Glutathione S-transferase	1993	127
Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction Marc Labelle, Michel Belley, Yves Gareau, Bioorganic & Medicinal Chemistry Letters InflammationAnti-inflammatoryFunctional SelectivityMedicineImmunology	1995	100

Page 1